X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (181534) 181534
Newspaper Article (10829) 10829
Newsletter (9544) 9544
Magazine Article (1977) 1977
Book Chapter (673) 673
Dissertation (600) 600
Web Resource (357) 357
Book / eBook (218) 218
Conference Proceeding (209) 209
Trade Publication Article (171) 171
Reference (108) 108
Publication (80) 80
Book Review (56) 56
Transcript (46) 46
Government Document (25) 25
Journal / eJournal (25) 25
Report (18) 18
Streaming Video (18) 18
Paper (16) 16
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (105162) 105162
male (63105) 63105
animals (55824) 55824
female (51997) 51997
anti-inflammatory agents - therapeutic use (37152) 37152
nonsteroidal anti-inflammatory drugs (29788) 29788
adult (29754) 29754
middle aged (28115) 28115
anti-inflammatory agents, non-steroidal - therapeutic use (27376) 27376
inflammation (26063) 26063
anti-inflammatory agents - pharmacology (25656) 25656
pharmacology & pharmacy (25542) 25542
anti-inflammatory drugs (22896) 22896
rats (22285) 22285
mice (22166) 22166
aged (19646) 19646
anti-inflammatory agents, non-steroidal - pharmacology (17449) 17449
anti-inflammatory agents, non-steroidal - adverse effects (15861) 15861
anti-inflammatory agents - administration & dosage (15291) 15291
research (15258) 15258
treatment outcome (15022) 15022
anti-inflammatory agents, non-steroidal - administration & dosage (12598) 12598
analysis (12564) 12564
anti-inflammatory (11293) 11293
pain (10256) 10256
adolescent (10149) 10149
care and treatment (9515) 9515
chemistry, medicinal (9506) 9506
dose-response relationship, drug (9214) 9214
risk factors (8903) 8903
immunology (8900) 8900
expression (8514) 8514
time factors (8473) 8473
disease models, animal (8460) 8460
anti-inflammatory agents (8456) 8456
biochemistry & molecular biology (7950) 7950
cytokines (7822) 7822
nonsteroidal antiinflammatory drugs (7697) 7697
medicine, general & internal (7643) 7643
anti-inflammatory agents - adverse effects (7471) 7471
health aspects (7454) 7454
child (7399) 7399
analgesics (7317) 7317
drug therapy (7162) 7162
inflammation - drug therapy (7007) 7007
drug therapy, combination (6850) 6850
gastroenterology & hepatology (6848) 6848
administration, topical (6779) 6779
drugs (6736) 6736
double-blind method (6705) 6705
rheumatology (6650) 6650
inhibition (6620) 6620
surgery (6610) 6610
arthritis (6584) 6584
rats, wistar (6350) 6350
oxidative stress (5990) 5990
activation (5870) 5870
rats, sprague-dawley (5846) 5846
aspirin (5789) 5789
therapy (5734) 5734
disease (5714) 5714
cells, cultured (5529) 5529
cancer (5493) 5493
anti-inflammatory agents, non-steroidal - chemistry (5372) 5372
anti-inflammatory agents - chemistry (5362) 5362
antioxidants (5327) 5327
nf-kappa-b (5299) 5299
cells (5253) 5253
apoptosis (5236) 5236
double-blind (5236) 5236
arthritis, rheumatoid - drug therapy (5186) 5186
aged, 80 and over (5142) 5142
cell line (5024) 5024
plant extracts - pharmacology (5022) 5022
administration, oral (5003) 5003
in-vitro (4890) 4890
macrophages (4818) 4818
medicine & public health (4813) 4813
prospective studies (4786) 4786
neurosciences (4729) 4729
corticosteroids (4721) 4721
steroids (4622) 4622
rheumatoid-arthritis (4590) 4590
cell biology (4587) 4587
dermatology (4570) 4570
medicine (4552) 4552
retrospective studies (4505) 4505
anti-inflammatory activity (4475) 4475
nitric oxide (4464) 4464
prevention (4425) 4425
young adult (4410) 4410
medical research (4314) 4314
studies (4311) 4311
patients (4267) 4267
follow-up studies (4201) 4201
ibuprofen (4165) 4165
risk (4143) 4143
research article (4112) 4112
proteins (4018) 4018
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (168) 168
Online Resources - Online (72) 72
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
UofT at Mississauga - Stacks (6) 6
Sunnybrook Health Sciences Centre - Holland Stacks (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Scarborough - Stacks (3) 3
Gerstein Science - Periodical Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Media Commons - Audio Visual (1) 1
Mt Sinai Hospital - Online (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (188485) 188485
German (4537) 4537
French (4002) 4002
Japanese (3830) 3830
Russian (2142) 2142
Spanish (1794) 1794
Italian (1524) 1524
Chinese (1344) 1344
Portuguese (1066) 1066
Polish (758) 758
Korean (612) 612
Dutch (332) 332
Danish (285) 285
Czech (235) 235
Swedish (201) 201
Hungarian (197) 197
Romanian (186) 186
Norwegian (184) 184
Turkish (130) 130
Croatian (128) 128
Finnish (104) 104
Ukrainian (99) 99
Slovak (74) 74
Bulgarian (69) 69
Hebrew (66) 66
Serbian (52) 52
Lithuanian (24) 24
Arabic (12) 12
Persian (12) 12
Bosnian (11) 11
Slovenian (7) 7
Afrikaans (5) 5
Icelandic (4) 4
Indonesian (4) 4
Greek (3) 3
Breton (1) 1
Catalan (1) 1
Latin (1) 1
Malay (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Advances in neuroimmunology, ISSN 0960-5428, 1991
Journal
Marine drugs, ISSN 1660-3397, 07/2011, Volume 9, Issue 7, pp. 1293 - 1306
Neorogioltriol is a tricyclic brominated diterpenoid isolated from the organic extract of the red algae Laurencia glandulifera. In the present study, the... 
NF-κB | Neorogioltriol | TNFα | COX-2 | Laurencia | Carrageenan | Anti-inflammatory | CELLS | CHEMISTRY, MEDICINAL | TNF alpha | NITRIC-OXIDE SYNTHASE | MACROPHAGES | ANTIBACTERIAL | MARINE NATURAL-PRODUCTS | NF-kappa B | carrageenan | INFLAMMATION | anti-inflammatory | LIPOPOLYSACCHARIDE | neorogioltriol | NF-KAPPA-B | TRANSCRIPTION FACTOR | Plant Extracts - toxicity | Diterpenes - toxicity | Laurencia - chemistry | Plant Extracts - pharmacology | Lipopolysaccharides - metabolism | Anti-Inflammatory Agents, Non-Steroidal - isolation & purification | Anti-Inflammatory Agents - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Dose-Response Relationship, Drug | Plant Extracts - metabolism | Dexamethasone - pharmacology | Time Factors | Anti-Inflammatory Agents - isolation & purification | Inflammation Mediators - antagonists & inhibitors | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Aspirin - pharmacology | Diterpenes - metabolism | Phytotherapy | Inflammation Mediators - physiology | Lipopolysaccharides - physiology | Disease Models, Animal | Diterpenes - pharmacology | Cell Survival - drug effects | Anti-Inflammatory Agents - pharmacology | Anti-Inflammatory Agents - toxicity | Diterpenes - isolation & purification | Rats | Plant Extracts - isolation & purification | Edema - drug therapy | Control Groups | Anti-Inflammatory Agents, Non-Steroidal - toxicity | Macrophages - metabolism | Animals | Arthritis - drug therapy | Macrophages - drug effects | Mice | Edema - chemically induced | Anti-Inflammatory Agents, Non-Steroidal | Edema | Inflammation Mediators | Aspirin | Dexamethasone | Anti-Inflammatory Agents | Plant Extracts | Cell Survival | Arthritis | Macrophages | Lipopolysaccharides | Life Sciences | Immunology | Diterpenes
Journal Article
Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 10/2017, Volume 42, Issue 5, pp. 656 - 660
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2015, Volume 148, Issue 7, pp. 1320 - 1329.e3
Background & Aims Infliximab, a tumor necrosis factor antagonist, is effective for treating patients with Crohn’s disease (CD) and ulcerative colitis (UC). We... 
Gastroenterology and Hepatology | Personalized Medicine | Pharmacokinetics | Therapeutic Drug Monitoring | Monoclonal Antibody | DOSE INTENSIFICATION | MAINTENANCE | THERAPY | CROHNS-DISEASE | EFFICACY | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | WITHDRAWAL | Drug Costs | Recurrence | Crohn Disease - economics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Male | Colitis, Ulcerative - immunology | Gastrointestinal Agents - economics | Antibodies, Monoclonal - blood | Drug Dosage Calculations | Anti-Inflammatory Agents - adverse effects | Infliximab | Crohn Disease - diagnosis | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Colitis, Ulcerative - drug therapy | Gastrointestinal Agents - pharmacokinetics | Anti-Inflammatory Agents - economics | Tertiary Care Centers | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Colitis, Ulcerative - blood | Crohn Disease - immunology | Remission Induction | Anti-Inflammatory Agents - blood | Algorithms | Belgium | Colitis, Ulcerative - diagnosis | Antibodies, Monoclonal - administration & dosage | Cost-Benefit Analysis | Crohn Disease - blood | Crohn Disease - drug therapy | Gastrointestinal Agents - adverse effects | Gastrointestinal Agents - blood | Colitis, Ulcerative - economics | Drug Monitoring | Antibodies, Monoclonal - economics | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Continuing medical education | Consulting services | Ulcerative colitis
Journal Article
Rheumatology international, ISSN 0172-8172, 2011, Volume 32, Issue 6, pp. 1491 - 1502
Non-steroidal anti-inflammatory drugs (NSAIDs) represent a diverse class of drugs and are among the most commonly used analgesics for arthritic pain worldwide,... 
Comparative efficacy | Comparative safety | Medicine & Public Health | Cyclooxygenase-2 inhibitors | Anti-inflammatory agents, non-steroidal | Rheumatology | Anti-inflammatory agents | Non-steroidal | COX-2 SELECTIVE INHIBITORS | RHEUMATOID-ARTHRITIS | CARDIOVASCULAR EVENTS | RHEUMATOLOGY | CLINICAL PHARMACOKINETICS | GASTROINTESTINAL SAFETY | non-steroidal | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | LONG-TERM USERS | PROTON PUMP INHIBITOR | DOUBLE-BLIND | CYCLO-OXYGENASE-2 INHIBITORS | Pain - prevention & control | Risk Assessment | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Nonprescription Drugs - classification | Practice Patterns, Physicians | Evidence-Based Medicine | Gastrointestinal Hemorrhage - epidemiology | Safety-Based Drug Withdrawals | Cyclooxygenase 2 Inhibitors - classification | Cyclooxygenase 2 Inhibitors - adverse effects | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Guideline Adherence | Patient Safety | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - chemically induced | Nonprescription Drugs - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - classification | Practice Guidelines as Topic | COX-2 inhibitors | Complications and side effects | Usage | Algorithms | Analgesics | Anti-inflammatory drugs | Nonsteroidal anti-inflammatory drugs | Comparative analysis | Epidemiology | Index Medicus | Review
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 06/2013, Volume 22, Issue 6, pp. 559 - 570
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10087, pp. 2375 - 2382
Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require... 
Internal Medicine | RHEUMATOID-ARTHRITIS | CYCLO-OXYGENASE-2 | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY | DICLOFENAC | PREVENTION | RISK | OSTEOARTHRITIS | Celecoxib - administration & dosage | Recurrence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Secondary Prevention - methods | Aspirin - administration & dosage | Cyclooxygenase 2 Inhibitors - adverse effects | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Aspirin - therapeutic use | Drug Therapy, Combination | Celecoxib - adverse effects | Naproxen - adverse effects | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Cyclooxygenase 2 Inhibitors - administration & dosage | Peptic Ulcer Hemorrhage - chemically induced | Celecoxib - therapeutic use | Proton Pump Inhibitors - therapeutic use | Naproxen - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Aged | Care and treatment | Aspirin | Anti-inflammatory drugs | Gastrointestinal diseases | Naproxen | Clinical trials | Arthritis | Complications and side effects | Medical research | Gastrointestinal bleeding | Medicine, Experimental | Drugs | Funding | Risk | Population studies | Hemorrhage | Evidence-based medicine | Bleeding | Incidence | Motivation | Safety | Nonsteroidal anti-inflammatory drugs | Digestive system | Risk reduction | Inflammation | Celecoxib | Patients | Anti-inflammatory agents | Diseases | Omeprazole | Random numbers | Inhibitors | Ulcers | Healing | Fatalities | Cyclooxygenase-2 | Cardiovascular diseases | Health risk assessment | Protons | Randomization | Analgesics | Endoscopy | Drug dosages | Mortality | Health risks | Hospitals
Journal Article